LYC Healthcare Berhad (KLSE:LYC)
0.0050
0.00 (0.00%)
At close: Aug 7, 2026
LYC Healthcare Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is April - March.
Millions MYR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 4 | 11 | 46 | 132 | 169 | 114 | |
Market Cap Growth | -75.00% | -76.12% | -64.86% | -21.73% | 48.49% | 7.66% |
Enterprise Value | 154 | 173 | 196 | 256 | 267 | 228 |
Last Close Price | 0.01 | 0.01 | 0.07 | 0.18 | 0.26 | 0.24 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Forward PE | - | 16.50 | 16.50 | 16.50 | 16.50 | 16.50 |
PS Ratio | 0.03 | 0.08 | 0.30 | 1.02 | 1.83 | 1.76 |
PB Ratio | 0.07 | 0.20 | 0.83 | 1.80 | 2.10 | 2.71 |
P/FCF Ratio | 0.15 | 0.46 | 2.02 | 26.28 | 68.72 | - |
P/OCF Ratio | 0.15 | 0.46 | 1.62 | 12.32 | 33.85 | 330.84 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.15 | 1.29 | 1.26 | 1.99 | 2.90 | 3.52 |
EV/EBITDA Ratio | 8.78 | 9.84 | 15.87 | 43.32 | 55.21 | 21.88 |
EV/EBIT Ratio | 187.67 | 217.14 | 46.30 | - | 170.58 | 29.79 |
EV/FCF Ratio | 6.36 | 7.12 | 8.52 | 50.93 | 108.67 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 2.18 | 2.18 | 2.48 | 1.88 | 1.43 | 2.95 |
Debt / EBITDA Ratio | 6.79 | 6.79 | 6.32 | 10.02 | 10.62 | 8.14 |
Debt / FCF Ratio | 4.91 | 4.91 | 5.99 | 27.45 | 46.86 | - |
Net Debt / Equity Ratio | 1.86 | 1.86 | 2.32 | 1.65 | 0.92 | 2.42 |
Net Debt / EBITDA Ratio | 5.80 | 5.80 | 10.45 | 20.49 | 15.39 | 9.80 |
Net Debt / FCF Ratio | 4.19 | 4.19 | 5.61 | 24.09 | 30.28 | -40.14 |
Asset Turnover | 0.59 | 0.59 | 0.64 | 0.55 | 0.46 | 0.41 |
Inventory Turnover | 7.33 | 7.33 | 8.50 | 6.30 | 7.39 | 9.56 |
Quick Ratio | 0.35 | 0.35 | 0.23 | 0.26 | 1.39 | 2.05 |
Current Ratio | 0.41 | 0.41 | 0.46 | 0.54 | 1.80 | 2.55 |
Return on Equity (ROE) | -24.62% | -24.62% | -18.89% | -21.44% | -24.13% | -12.58% |
Return on Assets (ROA) | 0.22% | 0.22% | 1.09% | -0.45% | 0.49% | 2.99% |
Return on Capital Employed (ROCE) | 0.80% | 0.80% | 3.60% | -1.20% | 0.90% | 4.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | -628.99% | -209.66% | -36.73% | -15.71% | -11.35% | -8.11% |
FCF Yield | 655.67% | 218.56% | 49.61% | 3.81% | 1.46% | -2.23% |
Buyback Yield / Dilution | 1.50% | 1.50% | - | -29.88% | -26.33% | -20.38% |